Issue |
Section |
Title |
File |
Vol 30, No 4 (2019) |
Articles |
The basics of the prevention and treatment of dry eye syndrome in patients with diabetes mellitus |
|
Vol 30, No 5 (2019) |
Articles |
The efficiency and safety of therapy for the main manifestations of dry eye syndrome in perimenopausal and postmenopausal women |
|
Vol 31, No 3 (2020) |
Articles |
EVALUATION OF THE EFFICIENCY OF METABOLIC THERAPY IN ELDERLY PATIENTS WITH CARBOHYDRATE METABOLISM DISORDERS AFTER ISCHEMIC STROKE |
|
Vol 31, No 10 (2020) |
Articles |
The role of diabetes mellitus and a gender factor in the development of a second noncardioembolic ischemic stroke |
|
Vol 31, No 10 (2020) |
Articles |
The importance of metabolic markers in the development of a second ischemic stroke |
|
Vol 31, No 11 (2020) |
Articles |
Construction of a predictive model for assessing the risk of noncardioembolic ischemic stroke |
|
Vol 30, No 2 (2019) |
Articles |
New possibilities for the treatment of dry eye syndrome in an internist’s practice |
|
Vol 23, No 3 (2012) |
Articles |
COGNITIVE DEFICIT IN PATIENTS WITH METABOLIC SYNDROME |
|
Vol 23, No 4 (2012) |
Articles |
BALANCE OF METABOLIC NEUTRALITY AND ANTIHYPERTENSIVE THERAPY EFFICIENCY |
|
Vol 23, No 4 (2012) |
Articles |
ADIPONECTIN LEVEL IN PATIENTS WITH METABOLIC SYNDROME WHO HAVE EXPERIENCED ACUTE CEREBRAL CIRCULATORY DISORDERS |
|
Vol 23, No 12 (2012) |
Articles |
SECONDARY PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH TYPE 2 DIABETES MELITUS |
|
Vol 24, No 3 (2013) |
Articles |
POSTSTROKE FRACTURES AND OSTEOPOROSIS: IT IS TIME TO THINK ABOUT PROTECTION |
|
Vol 24, No 4 (2013) |
Articles |
DEVELOPMENT OF COGNITIVE IMPAIRMENTS IN DIABETIC PATIENTS AFTER PREVIOUS ISCHEMIC STROKE |
|
Vol 24, No 7 (2013) |
Articles |
SAFETY OF HORMONAL CONTRACEPTIVES: THROMBOTIC RISK AND METABOLIC DISTURBANCES |
|
Vol 24, No 9 (2013) |
Articles |
CEREBROVASCULAR EVENTS IN PATIENTS WITH DIABETES MELLITUS |
|
Vol 24, No 11 (2013) |
Articles |
DIABETES MELLITUS AS A PATHOLOGY PREDISPOSING TO THE DEVELOPMENT OF RESPIRATORY DISEASES |
|
Vol 25, No 1 (2014) |
Articles |
PHYTOESTROGENS IN EARLY MANIFESTATIONS OF MENOPAUSAL SYNDROME IN WOMEN WITH CHRONIC BRAIN ISCHEMIA |
|
Vol 24, No 12 (2013) |
Articles |
THE DEVELOPMENT OF PRIMARY ISCHEMIC STROKE AND THE SPREAD OF DIFFERENT TYPES OF APOLIPOPROTEIN E GENE POLYMORPHISM IN A MOSCOW POPULATION |
|
Vol 27, No 9 (2016) |
Articles |
SAFE THERAPY FOR OSTEOARTHRITIS IN PATIENTS WITH COMORBIDITIES |
|
Vol 28, No 3 (2017) |
Articles |
EFFICIENCY OF THERAPY FOR SEASONAL ACUTE RESPIRATORY DISEASES IN PATIENTS WITH COMORBIDITIES |
|
Vol 27, No 11 (2016) |
Articles |
EFFICIENCY, SAFETY AND UNWARRANTED POLYPHARMACY IN THE TREATMENT OF ACUTE RESPIRATORY DISEASES |
|
Vol 28, No 7 (2017) |
Articles |
COMORBIDITY AND POLYPRAGMACY |
|
Vol 28, No 7 (2017) |
Articles |
EVALUATION OF THE EFFICACY OF NAFTIDROFURYLUM AS PART OF EARLY COMPREHENSIVE REHABILITATION IN PATIENTS WITH POSTSTROKE APHASIA |
|
Vol 29, No 7 (2018) |
Articles |
The foundation for stroke prevention in current clinical practice |
|
Vol 29, No 3 (2018) |
Articles |
ENDOTHELIAL PROTECTION IN THE REHABILITATION OF PATIENTS WITH POSTSTROKE APHASIA |
|
Vol 29, No 2 (2018) |
Articles |
Predictors of recurrent ischemic stroke |
|
Vol 29, No 4 (2018) |
Articles |
Evaluation of the efficiency and safety of lipid-lowering therapy in comorbid patients |
|
Vol 29, No 5 (2018) |
Articles |
Safe therapy for joint and back pain in a patient with comorbidity |
|
Vol 29, No 9 (2018) |
Articles |
Features of the development of cognitive impairment in patients with type 2 diabetes mellitus and metabolic syndrome |
|
Vol 29, No 11 (2018) |
Articles |
A rational approach to solving cardiometabolic problems in the therapy of comorbid patients |
|